WCG adds clinical trial benchmarking firms to portfolio

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Kritchanut)
(Image: Getty/Kritchanut)

Related tags: WCG, Benchmarking, Clinical trials, CRO, Contract research organization, Contract research

WCG’s acquisition of KMR Group and MCC addresses sponsor and CRO need to establish a common set of metrics to understand and manage clinical trial performance, says CEO.

KMR Group and Metrics Champion Consortium (MCC) will operate independently as part of the WIRB-Copernicus Group (WCG) Market Insights and Intelligence Division. The firms provide benchmarking, metrics, analytics and performance management in the clinical research and development space.

WCG will support the companies with access to capital, expertise, and corporate operational support, according to the clinical services organization.

“The sheer volume of clinical trial performance data available to sponsors and CROs has exploded over the past few years and many clinical trial leaders are struggling to operationalize these data in a consistent and actionable manner,”​ said Donald A. Deieso, PhD, executive chairman and CEO of WCG.

To keep up, Deieso told us “sponsors and CROs need to establish a common set of metrics to understand and manage clinical trial performance.”

“By bringing together these leading companies, we can address the growing need to establish standardized data benchmarks across the most critical areas of R&D and clinical trial execution.”

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us

Products

View more

Webinars